New report saves medical sales teams
It's been a tough year for medical sales teams around the UK as company after company had cut it's headcount to deal with changes in the market.
Reports on statins have been the latest threat to medical sales teams at AZ and indeed at other companies selling these drugs with concerns over whether the group of drugs may increase the incidence of cancer in patients.
Fortunately, the report has given the drugs a clean bill of health with no relationship found between the incidence of cancer bringing welcome relief to medical sales teams in the UK. It's been a year peppered with job losses as the industry attempts to reshape to deal with market changes. This would have been a terrible blow to medical sales people already shaken by changes to date.
Primary Care Representative
Poor medical sales advice given in UK pharmacies
